4-Methylmorpholine → HCID 67092312、化合物

HRID 2074101ノート

反応式

HRID 2074101 の反応式
[F:1][C:2]1[CH:23]=[CH:22][C:5]([CH2:6][C:7]2[N:11]([CH:12]3[CH2:15][NH:14][CH2:13]3)[N:10]=[C:9]([C:16]3[CH:21]=[CH:20][N:19]=[CH:18][CH:17]=3)[CH:8]=2)=[CH:4][CH:3]=1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.CN1CCOCC1.[NH:52]1[CH:56]=[CH:55][N:54]=[C:53]1[C:57](O)=[O:58]>CN(C=O)C.CCOCC>[F:1][C:2]1[CH:23]=[CH:22][C:5]([CH2:6][C:7]2[N:11]([CH:12]3[CH2:13][N:14]([C:57]([C:53]4[NH:52][CH:56]=[CH:55][N:54]=4)=[O:58])[CH2:15]3)[N:10]=[C:9]([C:16]3[CH:21]=[CH:20][N:19]=[CH:18][CH:17]=3)[CH:8]=2)=[CH:4][CH:3]=1

参加物

8

実験手順

To a suspension of 4-(5-(4-fluorobenzyl)-1-(azetidin-3-yl)-1H-pyrazol-3-yl)pyridine (85 mg, 0.28 mmol) in DMF (3 mL) was added HOBt (45 mg, 0.33 mmol), EDCI (64 mg, 0.33 mmol), NMM (76 μL, 0.69 mmol) followed by imidazole-2-carboxylic acid (34 mg, 0.30 mmol) and the mixture stirred for 16 hours at room temperature. The volatiles were removed in vacuo and the residue purified directly by Biotage flash chromatography, eluting with 2-6% MeOH/DCM to yield a clear gum. Ether was added (5 mL) and the mix sonicated to give a white precipitate that was filtered off, washed with ether and dried in-vacuo to yield the title compound as a white solid, 78 mg, 70%. 1H NMR (400 MHz, DMSO-D6) δ ppm 13.04-13.12 (m, 1 H), 8.54 (d, 2 H), 7.74 (d, 2 H), 7.25-7.32 (m, 2 H), 7.18 (t, 2 H), 7.03-7.12 (m, 1 H), 6.66 (s, 1 H), 5.33-5.46 (m, 1 H), 4.77-4.92 (m, 2 H), 4.26-4.36 (m, 2 H), 4.12 (s, 2 H); m/z (APCI+) for C22H19N6FO 403.1 (M+H)+.

後処理

  1. customThe volatiles were removed in vacuo
  2. customthe residue purified directly by Biotage flash chromatography
  3. washeluting with 2-6% MeOH/DCM
  4. customto yield a clear gum
  5. customthe mix sonicated
  6. customto give a white precipitate that
  7. filtrationwas filtered off
  8. washwashed with ether
  9. customdried in-vacuo

出典と根拠

ORDレコード
ord-e53f822b039c4820926e4064a6ac9be0
出典データセット
uspto-grants-2011_04
特許番号
US07919488B2

反応ノート

読み込み中…